Results of Coronary Artery Stenting in Elderly People with Chronic Heart Failure

Abstract

Coronary artery disease (CHD) is widespread among patients with heart failure (HF) and accounts for almost two-thirds of cases. The use of percutaneous coronary intervention (PCI) in patients with CAD has increased markedly, and numerous observational studies have suggested that it is associated with improved patient outcomes (Puja B. Parikh, MD, MPH, Deepak L. Bhatt, MD, MPH et al, 2021). There are no randomized data comparing the impact of PCI on clinical outcomes and myocardial deremodeling in patients with coronary artery disease with coronary artery stenting or modern drug therapy aimed at compliance. There is evidence of the effect of PCI in acute MI (with and without acute coronary syndrome), chronic CAD with reduced ejection fraction, and MI with preserved ejection fraction. Randomized clinical trials with sufficient confirmation are needed to study the outcomes of PCI in these various populations of patients with coronary artery disease. (J Am Coll Cardiol 2021;77:2432-47) © 2021 American College of Cardiology Foundation.